Home | News | Events | Press | Contact  

About UseNewsletterMessage BoardsAction CenterAdvocateWalk to End Alzheimer’sShopDonate

Find your chapter:

search by state

In My Community
Research Trials in NYC
Text Size controlsNormal font sizeMedium font sizeLarge font size

Through clinical trials, researchers test new ways to detect, treat and prevent Alzheimer's disease and dementia. Recruiting and retaining clinical trial participants is now the greatest obstacle, other than funding, to developing the next generation of Alzheimer's treatments.

We need your help. Without participation, finding a cure is virtually impossible.

People with Alzheimer’s, caregivers and healthy volunteers are all needed today to participate in Alzheimer’s and dementia research.

When you join a clinical trial, you have an opportunity to participate in vital research that could change the course of this disease and improve the lives of all those it affects. Your participation in clinical trials gives us optimism for today and promise for the future. Use the TrialMatch service above to find a clinical trial now.

Current Research Studies in New York City:

  1. Are you caring for a relative with dementia including Alzheimer’s and other types?
  2. How men and women experience their identity, boundaries, and challenges when they are in charge of taking care of an elderly family member: parent, uncle or aunt, grandparent, in-laws
  3. Has Alzheimer's or memory loss touched someone you love?
  4. Does your loved one have Alzheimer's? Is he or she taking Aricept?
  5. Research study for individuals age 55-95 with memory complaints
  6. Research Study on Stress and Health Behaviors
  7. A Study on Family Caregiving
  8. Does Writing Promote Health?
  9. NYU Studies Of Individuals with a Family History of Alzheimer's Disease 

A free service that makes it easy for people with Alzheimer's, caregivers, families and physicians to locate clinical trials based on personal criteria (diagnosis, stage of disease) and location.
Learn more

For information about Clinical Trials, please visit: Columbia University, New York University, Mount Sinai

Are you caring for a relative with dementia including Alzheimer’s and other types?

Columbia University Medical Center is conducting a study to compare 2 counseling interventions for helping caregivers of persons with dementia.
You can qualify for the study if you are:

  • Hispanic
  • Are a caregiver of a relative with dementia. This relative can be your spouse, partner, parent, sibling, child, cousin, aunt or uncle.

Participation includes receiving one of 2 counseling interventions for 6 months, social services support, and completing interviews at the beginning and end of the study. Study procedures will be conducted at a time and place of your preference. Your time conducting each interview will be compensated with $50 in addition to up to $50 in transportation costs

For more information call:
646.584.1166

 

How men and women experience their identity, boundaries, and challenges when they are in charge of taking care of an elderly family member: parent, uncle or aunt, grandparent, in-laws

My name is Guillermina Altomonte and I am a PhD student in Sociology at The New School, in New York City. I am doing research on how men and women experience their identity, boundaries, and challenges when they are in charge of taking care of an elderly family member: parent, uncle or aunt, grandparent, in-laws.

The way I am doing this study is through confidential interviews, which last between 1 and 2 hours, and they can be conducted in whatever schedule and location suits you best. Although unfortunately I cannot offer compensation in return (except for coffee or snacks), all of my earlier interviewees have expressed their deep satisfaction about the possibility of talking openly about their challenging experiences.

I would be very happy if you would like to share your experiences in an interview and be part of my research, which aims at adding to our knowledge about unpaid family care work. If you would like to meet me and hear more about my project, or ask for more information over e-mail or telephone, you can reach me at:

Phone number: (540) 760-7673
Email: altog301@newschool.edu

 

Has Alzheimer's or memory loss touched someone you love?

Parker Jewish Institute For Health Care & Rehabilitation
Explore a new option while continuing your current Alzheimer’s or memory loss treatment.
If you or someone you know is 66 to 90 years old and has Alzheimer’s, you may qualify for a local research study and receive at no cost:
• Investigational treatment for Alzheimer’s symptoms
• Study-related care from a local Alzheimer’s expert
• Compensation may be provided for time and travel

Contact our clinic at 718-289-2103 for more information to see if you may be eligible to participate.

Does your loved one have Alzheimer's? Is he or she taking Aricept?

The Rockefeller University Hospital is conducting a study testing a new drug that may slow or stop progression of Alzheimer's when taken with Aricept.

If eligible if they:

  • Are age 60-85
  • Have been diagnosed with mild Alzheimer's disease
  • Have been taking Aricept for at least 3 months
  • Are a non-smoker

What the Study involves

  • Taking the study drug or placebo for 6 months (all participants will continue to take Aricept during the study)
  • Blood work
  • MRIs
  • PET scans

For additional information, contact Recruitment Specialists at 1-800-RUCARES

 

Are you worried about your own memory or the memory of a loved one?

Do you or someone you care about have a family history of Dementia or Alzheimer’s Disease?

This is a research study for individuals age 55-95 with memory complaints.

If eligible, participants receive:
- Medical evaluation
- 1 year of treatment for memory deficits
- Memory/cognitive performance monitoring by experts
- Monetary compensation

If interested, please call (212) 543-5176

The study is conducted at New York State Psychiatric Institute/Columbia University Medical Center and is funded by the United States Department of Defense.

 

RESEARCH STUDY ON STRESS AND HEALTH BEHAVIORS

Do you currently help care for a parent with dementia or have a parent with demen4a in an assisted living facility? Are you a parent yourself? Are you a woman between the ages of 30 – 65?

If so, we are interested in learning about how this experience affects women’s health.

Participation involves an ONLINE SURVEY that will take approximately 30 minutes to complete. Participants who complete the survey can be entered into a raffle for a chance to win a $100 gift card.

For more information e-mail: caregiverpsychology@umsl.edu To take the survey go to: https://www.research.net/s/caregiverhealthsurvey2 Approved by the UMSL Ins4tu4onal Review Board: #315422‐1

 

PARTICIPANTS NEEDED FOR A STUDY ON FAMILY CAREGIVING

This study will explore the costs and rewards of caring for an elderly family member, such as a spouse, parent, aunt/uncle, grandparent, etc.
As a participant of this study, you will be asked to complete ONE anonymous, on-line survey, which takes approximately ten to fifteen minutes.

In appreciation of your time, you will be entered in a drawing to win an
Amazon.com gift certificate.

This study has been approved by the Institutional Review Board at Bard College. Contact: IRB@bard.edu


Does Writing Promote Health?

Are you the caregiver for a loved one who has Alzheimer’s Disease or other type of dementia?

If so, you are invited to participate in a University of Iowa web-based research study that will examine the effects writing may have on your health and the level of acceptance of the Web-based writing intervention to manage stress related to caregiving experiences.

You will be asked to write about your thoughts and feelings regarding caring for a family member or regarding activities related to care for one’s self for only 20 minutes on three separate days. There is no need to be a "good writer" or worry about spelling, grammar, or sentence structure. As a means to measure the effect of the writing on reducing stress, you will also be asked to compete 5 questionnaires that are all on the website .

Participants will be offered compensation.

If you would like more information and/or are interested in participating use the link below to view the study’s website at:
http://swee.its.uiowa.edu/swee

If you would like to speak with someone personally, you may email or call Ji Woon Ko using the contact information below:
Ji Woon Ko, RN; MSN
jiwoon-ko@uiowa.edu
Principal Investigator
University of Iowa
Iowa City, Iowa
319-594-0502

 

NYU Studies Of Individuals with a Family History of Alzheimer's Disease


To examine 1st degree relatives of patients with Alzheimer’s disease, who may themselves be at increased risk for Alzheimer’s disease. The major risk factor for developing Alzheimer’s disease is having a 1st degree relative with the disease. Children of parents affected with AD are at very high risk for developing AD as compared to individuals without a family history of AD. The reasons for the increased risk are not known. This project involves identification of biological mechanisms involved in maternally, and paternally, transmitted risk for Alzheimer’s disease. Results will provide new information on the genetic factors associated with late-onset Alzheimer’s, and possibly help refine models used to assess risk for Alzheimer’s disease in individuals with predisposition.   

Specifically, we will be studying brain activity, as reflected in brain glucose utilization, in healthy persons with a 1st degree family history of Alzheimer’s disease. Glucose is a sugar that is utilized by the brain for energy. Low sugar utilization reflects low brain activity.  Using positron emission tomography (PET) scans to image brain function, in 2007 we discovered that brain activity is reduced in healthy persons whose mother had Alzheimer’s disease, as compared to those whose father or other 1st degree relatives had the disease. These deficits were observed in the same regions of the brain that are typically affected in Alzheimer’s patients.

The goal of our study is to explore the impact of having a maternal and/or paternal family history of Alzheimer's disease on brain activity (i.e., glucose metabolism) in young adults. While we previously worked with individuals older than 50 yrs, we are now focusing in younger adults, of age between 20-50 yrs.

Brain glucose metabolism will be measured using brain PET imaging and a tracer called Fluorodeoxyglucose (FDG), which is used to measure glucose utilization in brain.
This research team will examine whether 20-50 year old individuals with a family history of Alzheimer’s show reduced brain glucose metabolism compared to a group of individuals with no family history of AD. A secondary objective is to examine whether reductions in brain activity are more severe in those individuals with a multigenerational history of Alzheimer’s as compared to those who do not. We are particularly interested in working with individuals with the mother and the maternal grandmother affected with Alzheimer’s, and with individuals with the father and the paternal grandfather affected with Alzheimer’s.
Specific Goals:

  • To examine whether having an AD-affected parent (mother or father, or both) predisposes children to brain metabolic impairment.
  • To understand whether individuals with an AD-affected mother are at higher risk as compared to individuals with an AD-father, and to individuals with no parents affected.
  • To understand whether individuals with a multigenerational family history of Alzheimer’s (i.e., parents and grandparents with Alzheimer’s) are at higher risk as compared to individuals with unigenerational family history (i.e., only parents affected with Alzheimer’s).

Should you be interested in learning more about the study, please do not hesitate to contact us. Our study coordinator, John Murray, BA, can be reached at 212 263 7795, or by email: John.Murray@nyumc.org

 
 

 

 


 

Alzheimer's Association

Our vision is a world without Alzheimer's
Formed in 1980, the Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research.